Crystal structure of a soluble CD28-Fab complex

被引:146
作者
Evans, EJ
Esnouf, RM
Manso-Sancho, R
Gilbert, RJC
James, JR
Yu, C
Fennelly, JA
Vowles, C
Hanke, T
Walse, B
Hünig, T
Sorensen, P
Stuart, DI
Davis, SJ
机构
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England
[3] TeGenero AG, D-97076 Wurzburg, Germany
[4] Act Biotech Res AB, SE-22007 Lund, Sweden
[5] Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany
基金
英国惠康基金; 英国医学研究理事会;
关键词
D O I
10.1038/ni1170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Naive T cell activation requires signaling by the T cell receptor and by nonclonotypic cell surface receptors. The most important costimulatory protein is the monovalent homodimer CD28, which interacts with CD80 and CD86 expressed on antigen-presenting cells. Here we present the crystal structure of a soluble form of CD28 in complex with the Fab fragment of a mitogenic antibody. Structural comparisons redefine the evolutionary relationships of CD28-related proteins, antigen receptors and adhesion molecules and account for the distinct ligand-binding and stoichiometric properties of CD28 and the related, inhibitory homodimer CTLA-4. Cryo-electron microscopy-based comparisons of complexes of CD28 with mitogenic and nonmitogenic antibodies place new constraints on models of antibody-induced receptor triggering. This work completes the initial structural characterization of the CD28-CTLA-4-CD80-CD86 signaling system.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 53 条
[1]   CD28-mediated co-stimulation: A quantitative support for TCR signalling [J].
Acuto, O ;
Michel, F .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (12) :939-951
[2]   A dissection of specific and non-specific protein - Protein interfaces [J].
Bahadur, RP ;
Chakrabarti, P ;
Rodier, F ;
Janin, J .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 336 (04) :943-955
[3]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[4]  
Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789
[5]   LICOS, a primordial costimulatory ligand? [J].
Brodie, D ;
Collins, AV ;
Iaboni, A ;
Fennelly, JA ;
Sparks, LM ;
Xu, XN ;
van der Merwe, PA ;
Davis, SJ .
CURRENT BIOLOGY, 2000, 10 (06) :333-336
[6]   The immunological synapse and CD28-CD80 interactions [J].
Bromley, SK ;
Iaboni, A ;
Davis, SJ ;
Whitty, A ;
Green, JM ;
Shaw, AS ;
Weiss, A ;
Dustin, ML .
NATURE IMMUNOLOGY, 2001, 2 (12) :1159-1166
[7]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[8]  
BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
[9]   Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells:: Application to glycoprotein crystallization [J].
Butters, TD ;
Sparks, LM ;
Harlos, K ;
Ikemizu, S ;
Stuart, DI ;
Jones, EY ;
Davis, SJ .
PROTEIN SCIENCE, 1999, 8 (08) :1696-1701
[10]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53